Congress Must Update FDA Regulations for Medical AI

This is the authors' abstract. We don't add key points for this paper.

This JAMA Forum discusses pending legislation in the US House and Senate and the history of the “firm-based approach” the US Food and Drug Administration (FDA) could use when regulating artificial intelligence (AI) medical devices to augment patient care.